SIGN UP

April 7, 2025 10:18 AM EDT

Lexeo discloses new data for heart drug; Spark Therapeutics to lay off workers

ENDPOINTS

Plus, news about Kashiv BioSciences:

Lexeo Therapeutics reveals early data for heart disease drug: The New York biotech said LX2006

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma

Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

Rare disease hub at CDER and CBER faces new reality with staff crunch

RFK Jr. won’t testify before key Senate committee this week on HHS overhaul

HHS says it may revisit anti-obesity drug policies after dropping Biden-era proposal

PureTech rejects cash exit proposal from Nordic Capital, investment firm says it won't make an offer